GB9105677D0 - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- GB9105677D0 GB9105677D0 GB919105677A GB9105677A GB9105677D0 GB 9105677 D0 GB9105677 D0 GB 9105677D0 GB 919105677 A GB919105677 A GB 919105677A GB 9105677 A GB9105677 A GB 9105677A GB 9105677 D0 GB9105677 D0 GB 9105677D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919105677A GB9105677D0 (en) | 1991-03-19 | 1991-03-19 | Heterocyclic compounds |
GB9204887A GB2253848A (en) | 1991-03-19 | 1992-03-05 | Heterocyclic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919105677A GB9105677D0 (en) | 1991-03-19 | 1991-03-19 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9105677D0 true GB9105677D0 (en) | 1991-05-01 |
Family
ID=10691744
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919105677A Pending GB9105677D0 (en) | 1991-03-19 | 1991-03-19 | Heterocyclic compounds |
GB9204887A Withdrawn GB2253848A (en) | 1991-03-19 | 1992-03-05 | Heterocyclic compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9204887A Withdrawn GB2253848A (en) | 1991-03-19 | 1992-03-05 | Heterocyclic compounds |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB9105677D0 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1415987B1 (en) | 2000-10-20 | 2007-02-28 | Eisai R&D Management Co., Ltd. | Nitrogenous aromatic ring compounds as anti cancer agents |
JP2004517851A (en) | 2000-12-27 | 2004-06-17 | バイエル アクチェンゲゼルシャフト | Indole derivatives as thyroid receptor ligands |
US7186745B2 (en) | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
JPWO2004080462A1 (en) | 2003-03-10 | 2006-06-08 | エーザイ株式会社 | c-Kit kinase inhibitor |
CN101337930B (en) | 2003-11-11 | 2010-09-08 | 卫材R&D管理有限公司 | Urea derivative preparation process |
EP1797881B1 (en) | 2004-09-17 | 2009-04-15 | Eisai R&D Management Co., Ltd. | Medicinal composition with improved stability and reduced gelation properties |
EP2281901B1 (en) | 2005-08-02 | 2013-11-27 | Eisai R&D Management Co., Ltd. | Anti-tumour pharmaceutical composition with angiogenesis inhibitors |
US20090053236A1 (en) | 2005-11-07 | 2009-02-26 | Eisai R & D Management Co., Ltd. | USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
EP2036557B1 (en) | 2006-05-18 | 2015-10-21 | Eisai R&D Management Co., Ltd. | Antitumor agent for thyroid cancer |
KR101472600B1 (en) | 2006-08-28 | 2014-12-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Antitumor agent for undifferentiated gastric cancer |
JP5319306B2 (en) | 2007-01-29 | 2013-10-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Composition for treatment of undifferentiated gastric cancer |
US8952035B2 (en) | 2007-11-09 | 2015-02-10 | Eisai R&D Management Co., Ltd. | Combination of anti-angiogenic substance and anti-tumor platinum complex |
CN102958523B (en) | 2010-06-25 | 2014-11-19 | 卫材R&D管理有限公司 | Antitumor agent using compounds having kinase inhibitory effect in combination |
WO2012144463A1 (en) | 2011-04-18 | 2012-10-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Therapeutic agent for tumor |
US9945862B2 (en) | 2011-06-03 | 2018-04-17 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
BR112015009004A8 (en) | 2012-12-21 | 2021-07-20 | Eisai R&D Man Co Ltd | amorphous form of quinoline derivative and method of production thereof |
MX368099B (en) | 2013-05-14 | 2019-09-19 | Eisai R&D Man Co Ltd | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds. |
HRP20221047T1 (en) | 2014-08-28 | 2022-11-11 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
CN107427505A (en) | 2015-02-25 | 2017-12-01 | 卫材R&D管理有限公司 | For the method for the bitter taste for suppressing quinoline |
WO2016140717A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharp & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
US11369623B2 (en) | 2015-06-16 | 2022-06-28 | Prism Pharma Co., Ltd. | Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor |
US20210235697A1 (en) * | 2017-03-08 | 2021-08-05 | University Of Washington | Plant growth regulator |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790391A (en) * | 1971-10-20 | 1973-04-20 | Squibb & Sons Inc | THIAZOLINYLINDOLES AND THIAZINYLINDOLES, THEIR PREPARATION AND THEIR THERAPEUTIC USES |
-
1991
- 1991-03-19 GB GB919105677A patent/GB9105677D0/en active Pending
-
1992
- 1992-03-05 GB GB9204887A patent/GB2253848A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB9204887D0 (en) | 1992-04-22 |
GB2253848A (en) | 1992-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9125001D0 (en) | Heterocyclic compounds | |
GB9105677D0 (en) | Heterocyclic compounds | |
GB9113626D0 (en) | Heterocyclic compounds | |
GB9205484D0 (en) | Heterocyclic compounds | |
GB9205507D0 (en) | Heterocyclic compounds | |
GB9121727D0 (en) | Heterocyclic compounds | |
GB9104838D0 (en) | Heterocyclic compounds | |
GB9123916D0 (en) | Heterocyclic compounds | |
GB9104832D0 (en) | Heterocyclic compounds | |
GB9205485D0 (en) | Heterocyclic compounds | |
GB9111131D0 (en) | Heterocyclic compounds | |
GB9104769D0 (en) | Heterocyclic compounds | |
GB9205487D0 (en) | Heterocyclic compounds | |
GB9117987D0 (en) | Heterocyclic compounds | |
GB9204859D0 (en) | Heterocyclic compounds | |
AP9200435A0 (en) | Heterocyclic compounds | |
GB9215645D0 (en) | Heterocyclic compounds | |
GB9104870D0 (en) | Heterocyclic compounds | |
GB9106604D0 (en) | Heterocyclic compounds | |
GB9106714D0 (en) | Heterocyclic compounds | |
GB9106715D0 (en) | Heterocyclic compounds | |
GB9108217D0 (en) | Heterocyclic compounds | |
GB9108358D0 (en) | Heterocyclic compounds | |
GB9106655D0 (en) | Heterocyclic compounds | |
GB9111759D0 (en) | Heterocyclic compounds |